"FDA Approves World’s First CRISPR Gene-Editing Treatment for Sickle Cell Disease"
On December 8, 2023, the U.S. Food and Drug Administration (FDA) approved Casgevy™ (exagamglogene autotemcel), the first-ever CRISPR-Cas9 gene-editi...
Read Full Article